Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hyuk-Sang Kwon, MD
The Catholic University of KOREA, Yeouido St.Mary's Hostital in Korea
Principal Investigator - In Kyung Jeong, MD
Kyung Hee University Hospital at Gangdong in Korea
Principal Investigator - Jae Hyeon Kim, MD
Samsung Medical Center in Korea
Principal Investigator - Jae-Heon Kang, MD
Kangbuk Samsung Hospital, Samsung Medical Center in Korea
Principal Investigator - Jang Won Son, MD
The Catholic University of KOREA, Bucheon St.Mary's Hostital in Korea
Principal Investigator - Jun Hwa Hong, MD
Daejeon Eul Ji Medical Center, Eul Ji University in Korea
Principal Investigator - Kyu Chang Won, MD
Yeungnam University Medical Center in Korea
Principal Investigator - Kyung Wan Min, MD
Nowon Eul Ji Medical Center, Eul Ji University in Korea
Principal Investigator - Nan Hee Kim, MD
KOREA University Asan Hospital in Korea
Principal Investigator - Sang Youl Rhee, MD
Kyung Hee University, Medical Center in Korea
Principal Investigator - Seung-Hwan Lee, MD
The Catholic University of KOREA, Seoul St.Mary's Hostital in Korea
Principal Investigator - Sin Gon Kim, MD
KOREA University Anam Hospital, Seoul, South Korea
Principal Investigator - Soo Lim, MD
Seoul National University Bundang Hospital in Korea
Principal Investigator - Yong-Ho Lee, MD
Severance Hostital in Korea
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Catholic University of Korea, Bucheon St.Mary'S Hostital
Bucheon-si, South Korea
- Yeungnam University Medical Center
Daegu, South Korea
- Daejeon Eul Ji Medical Center, Eul Ji University
Daejeon, South Korea
- Seoul National University Bundang Hospital
Seongnam, South Korea
- Korea University Anam Hospital
Seoul, South Korea
- Korea University Asan Hospital
Seoul, South Korea
- Kangbuk Samsung Hospital, Samsung Medical Center
Seoul, South Korea
- Kyung Hee University Hospital at Gangdong
Seoul, South Korea
- Kyung Hee University, Medical Center
Seoul, South Korea
- Nowon Eul Ji Medical Center, Eul Ji University
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Severance Hostital
Seoul, South Korea
- the Catholic University of Korea, Seoul St.Mary'S Hostital
Seoul, South Korea
- the Catholic University of Korea, Yeouido St.Mary'S Hostital in Korea
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Dec 2024
- Primary completion
- 30 Oct 2025
- Completion
- 30 Oct 2025
- Last update posted
- 11 Jul 2025
- Registered enrollment
- 144
- Registry id
- NCT06712615
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.